Sofinnova Partners: Early-stage VC Investment




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Sofinnova Partners: Early-stage VC Investment
Released on: October 01, 2007. © PharmaVentures Ltd
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    In this second exclusive interview live from Geneva, Fintan Walton talks to Graziano Seghezzi, Partner at France-based venture capital (VC) firm Sofinnova Partners.
  • Summary
  • Participants
  • Company
In this second exclusive interview live from Geneva, Fintan Walton talks to Graziano Seghezzi, Partner at France-based venture capital (VC) firm Sofinnova Partners. With about half of the firm’s investments placed in the life sciences, Graziano talks about the company’s established and successful, if somewhat unusual, strategy to finance only early-stage companies. Actelion is given as an example of one of its success stories. The discussion moves on to the subject of exit strategies, and whether acquisition is a viable alternative to IPO. Graziano gives his opinion on how the European IPO market is faring at present, as well as how the European biotech sector is doing as a whole and why it has become increasingly attractive to US investors.
Graziano Seghezzi

After graduating from the University of Pavia in Genetics and Microbiology, Graziano spent 5 years as a biomedical researcher at New York University’s School of Medicine and also obtained an MBA from RSM Erasmus University. His career in VC started at Sofinnova Partners, where he initially worked to identify new investment opportunities in pharmaceutical and medical device companies in Italy. Graziano then joined Index Ventures in Geneva for 3 years, where he invested in biotechnology and biopharmaceuticals companies. He joined Sofinnova Partners as a Partner in 2006.
Sofinnova Partners